Healius Limited · ASX:HLS
Healius — Shareholder Meeting (October 2020)
16 slides from Healius's shareholder meeting presentation, Oct 22, 2020
Slide 1: 2020 Annual General Meeting
2020 Annual General Meeting For personal use only 22 October 2020
Slide 2: Robert Hubbard, Chair
Robert Hubbard Chair For personal use only 2 2020 Annual General Meeting
Slide 3: Virtual AGM Assistance
Virtual AGM Assistance For personal use only If you require assistance during the meeting, call: + 61 3 9415 4024 3 2020 Annual General Meeting
Slide 4: Board of Directors
Board of Directors For personal use only Robert Hubbard Arlene Tansey Sally Evans Dr Malcolm Parmenter Non-executive Chairman Non-executive Director Non-executive Director MD & CEO Dr Paul Jones Gordon Davis Charles Tilley Non-executive Director Non-executive Director Company Secretary 4 2020 Annual
Slide 5: COVID-19
COVID-19 We are grateful for the responses from our people, our businesses and our communities For personal use only Healius is a purpose-led organisation caring for the health and wellbeing of Australians at every stage of life 5 2020 Annual General Meeting
Slide 6: FY 2020 – a year in review
FY 2020 – a year in review Group Underlying Reported For personal use only $m FY 2020 FY 2019 FY 2020 FY 2019 Revenue 1,600.4 1,565.4 1,597.4 1,566.4 EBIT 102.7 125.9 76.0 107.6 NPAT (continuing operations) 55.4 70.3 72.0 57.2 NPAT (inc. discontinued operations) (70.5) 55.3 Going forward, Healius wi
Slide 7: Dividends and Capital Management
Dividends and Capital Management For personal use only • Look to resume regular dividends in the first half of 2021 • Considering capital management and returns to shareholders with proceeds from Healius Primary Care sale 7 2020 Annual General Meeting
Slide 8: Board Changes
Board Changes For personal use only • Thank you to Arlene who has served as Non- executive Director of Healius since August 2012 • Jenny McDonald will commence as Non-executive Director in November 2020 • Board is looking for another new Non-Executive Directors • 40:40:20 diversity target by 12/21 8
Slide 9: Robert Hubbard, Chair
Robert Hubbard Chair For personal use only 9 2020 Annual General Meeting
Slide 10: Dr Malcolm Parmenter, Managing Director & CEO
Dr Malcolm Parmenter Managing Director & CEO For personal use only 10 2020 Annual General Meeting
Slide 11: Executive Leadership Team
Executive Leadership Team For personal use only Malcolm Parmenter John McKechnie Ben Korst Dean Lewsam Scott Beattie MD & CEO Chief Executive, Chief Executive, Chief Executive, Chief Executive, Pathology Day Hospitals Imaging Medical Centres Maxine Jaquet Peter Wilson Janet Payne Mark Neeham Chief F
Slide 12: Trading Update
Trading Update • 1QFY21 Continuing operations1 For personal use only o Revenue of $492.5m, EBIT $81.2m o Benefits of strong trading, learnings from national lock-down and cost savings from SIP • Pathology: o Non-COVID revenue now ahead of pcp o Community COVID tests currently 7-10k w/day o Commercia
Slide 13: Strategy: Sustainable Improvement Program
Strategy: Sustainable Improvement Program For personal use only • Focus on delivering margin expansion • Higher value structural improvements • Next three years to focus on: Digitisation & Network Workforce External spend automation optimisation management reduction More streamlined business with st
Slide 14: Strategy: Growth
Strategy: Growth For personal use only • Build substantial 3rd business in Day (Short-stay) Hospitals: o Strong economic, technological and regulatory tailwinds o Continue ramp-up of new Montserrat facilities o Selective greenfield, brownfield and M&A • Pathology and Imaging: o Selective opportuniti
Slide 15: Sustainability
Sustainability For personal use only • Committed to delivering bulk-billed services • People are at the core of our strategy • Develop a pathway to a carbon neutral future • Develop a charitable foundation to support healthcare in disadvantaged sectors 15 2020 Annual General Meeting
Slide 16: For personal use only
For personal use only